Yin, Jiale, Author at MediaMedic

2024 CASH | ProfessorJianXiang Wang : Innovating Research and Standardizing Quality Control to Promote the Healthy Development of Hematology in China

By Yin, Jiale 2024.01.26

Editor's Note Welcoming a new chapter in hematology, the Fourth China Hematology Development Conference (CASH), organized by the Peking Union Medical College of the Chinese Academy of Medical Sciences and…

2024 CASH | Professor Hui Wei : Nurturing Growth in AML Treatment with Spring Breeze, Looking Forward to the Future of Immunotherapy

By Yin, Jiale 2024.01.26

Acute Myeloid Leukemia (AML), a group of malignancies originating from hematopoietic stem cells, stands as the most prevalent hematologic malignancy and has always been a focal point in both basic…

2024 CASH | Professor Gang An : Continuous Innovation in CAR-T Therapy, A New Dawn in MM Treatment!

By Yin, Jiale 2024.01.26

The Fourth China Hematology Development Conference was held in Tianjin from January 5th to 7th, 2024. Themed "Broadening Hematology, Healthcare, and Wellness," the conference focused on the core development directions…

2024 CASH | Professor ChunYan Ji : Significant Advances in Leukemia Treatment, Aiming to Achieve Treatment-Free Remission for More Patients

By Yin, Jiale 2024.01.26

Leukemia is a serious disease that poses a significant threat to public health, characterized by high mortality rates and challenging treatments. Fortunately, recent years have witnessed remarkable progress in the…

SABCS 2023丨An Interview with Dr. Santiago Escriva-de-Romanion the Novel Zaniratamab Combinations for HR+/HER2+ mBC

By Yin, Jiale 2024.01.25

Editor's Note: At the 2023 SABCS congress, We interviewed with Dr. Santiago Escriva-de-Romani from Vall d’Hebron Institute of Oncology (VHIO), explored the revolutionary advancements in breast cancer treatment, focusing on the introduction of the…

SABCS 2023丨Treatment Approach for Leptomeningeal Carcinomatosis in Advanced Breast Cancer Patients: Antibody-Drug Conjugate Trastuzumab Deruxtecan

By Yin, Jiale 2024.01.25

Editor's Note: The antibody-drug conjugate trastuzumab deruxtecan (T-DXd) has demonstrated significant activity in the treatment of in patients with advanced breast cancer (ABC), and as a result, it is widely…

Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

By Yin, Jiale 2024.01.22

In December 2023, a study led by Professor Bo Huang and his team from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, was published in the prestigious international…

Targeting Gut Microbial Nitrogen Recycling for Bortezomib Resistance in Multiple Myeloma

By Yin, Jiale 2024.01.22

In December 2023, a study led by Professors Wen Zhou from Central South University and Professor Wei Jia from Hong Kong Baptist University was published in the top international academic journal Cell Metabolism (IF=31.373), titled…

Deciphering STING-Driven Platelet Activation in Septic Thrombosis: A Comprehensive Study Unveiling Molecular Mechanisms and Therapeutic Avenues

By Yin, Jiale 2024.01.22

In May 2023, a study led by Professor JunLing Liu from the School of Medicine, Shanghai Jiao Tong University, was published in the prestigious international academic journal ——Immunity (IF=43.474). The research, titled "STING…

Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

By Yin, Jiale 2024.01.22

In March 2023, a study led by the team of Professor Tao Cheng from the Blood Disease Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of…